|
2019 |
Animal Models for the Study of Bone-Derived Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder. |
Jeffrey J. Lochhead, PhD |
|
2014 |
Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling. |
Nam Lee, Ph.D. |
|
2006 |
AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells. |
|
|
2021 |
ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2022 |
Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer's Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients. |
Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D. |
|
2015 |
Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2005 |
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. |
Jeffrey J. Lochhead, PhD |
|
2005 |
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. |
Jeffrey J. Lochhead, PhD |
|
2014 |
Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. |
John M. Streicher, PhD |
|
2016 |
Biphalin: The Foundation of Bivalent Ligands. |
|
|
2015 |
Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2017 |
Blocking CRMP2 SUMOylation reverses neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. |
Patrick T Ronaldson, PhD, FAAPS |
|
2022 |
Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2016 |
Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention. |
Roberta Diaz Brinton, Ph.D |
|
2019 |
Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions |
Christopher Cartmell |
|
2019 |
Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions. |
Christopher Cartmell |
|
2013 |
Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects. |
Peg Davis, Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2013 |
Cancer-induced bone pain: Mechanisms and models. |
Todd Vanderah, PhD |
|
2020 |
Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression. |
Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2014 |
Capsaicin-responsive corneal afferents do not contain TRPV1 at their central terminals in trigeminal nucleus caudalis in rats. |
Tally Largent-Milnes, PhD |
|
2019 |
Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2001 |
cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. |
|
